FEATURE: Hybrigenics Divides Proteins in Hopes of Conquering Yeast Two-Hybrid Market | GenomeWeb

PARIS, Dec 18 - The yeast two-hybrid method, first developed in 1989 by Stanley Fields, has provided the basis for a swift, high-throughput industrial process used to make protein-protein interaction maps. Established companies such as CuraGen and Myriad have each adapted the methodology and use it as part of their respective drug discovery platforms.

Now Hybrigenics of Paris is hoping that its technique, which uses protein fragments rather than whole proteins, will dominate the next generation of high-throughput yeast two-hybrid screening techniques.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.